Article

Exonuclease ISG20 inhibits human cytomegalovirus replication by inducing an innate immune…

medRxiv · 2025 · Hehl, M.; Scherer, M.; Raubuch, E.-M.; Ploil, C.; Rummel, T.; Kirchner, P.; Kottmann, N.; Reichel, A.; Kuderna, A. K.; Koenig, A.-C.; Friedel, C. C.; Erhard, F.; Stamminger, T.

Key facts

Title Exonuclease ISG20 inhibits human cytomegalovirus replication by inducing an innate immune defense signature
First author Hehl, M.; Scherer, M.; Raubuch, E.-M.; Ploil, C.; Rummel, T.; Kirchner, P.; Kottmann, N.; Reichel, A.; Kuderna, A. K.; Koenig, A.-C.; Friedel, C. C.; Erhard, F.; Stamminger, T.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.02.10.637376
Devices mentioned K010696, K202641, K231013
Product codes mentioned CIT, JJH, JJQ, JQW, MVU, OHQ, PFF, PFT, JIS, QBD

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature